Tumor-Intrinsic PD-L1 Exerts an Oncogenic Function through the Activation of the Wnt/β-Catenin Pathway in Human Non-Small Cell Lung Cancer

Programmed death ligand 1 (PD-L1) strongly inhibits T cell activation, thereby aiding tumors in escaping the immune response. PD-L1 inhibitors have proven to be effective in the treatment of different types of cancer, including non-small cell lung cancer (NSCLC). Yet, the knowledge regarding the bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yunxia, Marinkova, Rumyana, Nenkov, Miljana, Jin, Lai, Huber, Otmar, Sonnemann, Jürgen, Peca, Natália, Gaßler, Nikolaus, Chen, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569632/
https://www.ncbi.nlm.nih.gov/pubmed/36232331
http://dx.doi.org/10.3390/ijms231911031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569632/
https://www.ncbi.nlm.nih.gov/pubmed/36232331
http://dx.doi.org/10.3390/ijms231911031

Ejemplares similares